Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Feb 1;171(2):439-48.
doi: 10.1084/jem.171.2.439.

The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis

Affiliations

The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis

K Saukkonen et al. J Exp Med. .

Abstract

Cytokines mediate many host responses to bacterial infections. We determined the inflammatory activities of five cytokines in the central nervous system: TNF-alpha, IL-1 alpha, IL-1 beta, macrophage inflammatory protein 1 (MIP-1), and macrophage inflammatory protein 2 (MIP-2). Using a rabbit model of meningeal inflammation, each cytokine (except IL-1 beta) induced enhanced blood brain barrier permeability, leukocytosis in cerebrospinal fluid, and brain edema. Homologous antibodies to each mediator inhibited leukocytosis and brain edema, and moderately decreased blood brain barrier permeability. In rabbits treated with anti-CD-18 antibody to render neutrophils dysfunctional for adhesion, each cytokine studied lost the ability to cause leukocytosis and brain edema. After intracisternal challenge with pneumococci, antibodies to TNF or IL-1 prevented inflammation, while anti-MIP-1 or anti-MIP-2 caused only a 2-h delay in the onset of inflammation. We suggest these cytokines have multiple inflammatory activities in the central nervous system and contribute to tissue damage during pneumococcal meningitis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1988 Aug 18;319(7):397-400 - PubMed
    1. J Clin Invest. 1988 Jun;81(6):1925-37 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Jan;86(2):612-6 - PubMed
    1. FEBS Lett. 1989 Feb 27;244(2):487-93 - PubMed
    1. Science. 1989 Feb 24;243(4894 Pt 1):1066-8 - PubMed

Publication types